tiprankstipranks
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
Holding AMRX?
Track your performance easily

Amneal Pharmaceuticals (AMRX) Ownership - Who Owns Amneal Pharmaceuticals?

486 Followers

Amneal Pharmaceuticals (AMRX) Ownership Overview

25.77%8.67%12.89%8.88%43.79%
25.77% Insiders
12.89% Other Institutional Investors
8.88% ETFs
43.79% Public Companies and
Individual Investors
The ownership structure of Amneal Pharmaceuticals (AMRX) stock is a mix of institutional, retail, and individual investors. Approximately 30.43% of the company’s stock is owned by Institutional Investors, 25.77% is owned by Insiders, and 43.79% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 19, 2024
xxxxxxxxxxxxx
$375887
Aug 16, 2024
xxxxxxxxxxxxx
$491382
Aug 16, 2024
xxxxxxxxxxxxx
$775000
May 20, 2024
xxxxxxxxxxxxx
$255942

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$1747200

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
26,856,413Insider8.80%225,862,433
25,265,818Insider8.15%212,485,529
21,781,986Insider7.03%183,186,502
13,896,187Institution4.48%116,866,933
11,957,543Institution3.86%100,562,937
6,691,398Institution2.16%56,274,657
2,234,623Institution0.72%18,793,179
2,048,886Insider0.66%17,231,131
1,959,627Institution0.63%16,480,463
1,808,584Institution0.58%15,210,191

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
11,957,543Institution3.86%100,562,937
1,959,627Institution0.63%16,480,463
1,808,584Institution0.58%15,210,191
1,473,400Institution0.48%12,391,294
1,383,340Institution0.45%11,633,889
1,319,570Institution0.43%11,097,584
1,056,854Institution0.34%8,888,142
903,340Institution0.29%7,597,089
799,405Institution0.26%6,722,996
597,792Institution0.19%5,027,431

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,429,753Institution1.43%37,387,115
4,357,263Institution1.41%36,252,428
3,498,775Institution1.13%29,634,624
2,360,216Institution0.76%19,991,030
2,161,848Institution0.70%17,986,575
1,192,588Institution0.38%10,065,443
1,092,146Institution0.35%9,097,576
753,758Institution0.24%6,384,330
748,865Institution0.24%6,238,045
729,248Institution0.24%6,067,343

FAQ

Who Owns Amneal Pharmaceuticals Inc (AMRX)?
According to the latest TipRanks data, approximately 12.89% of the company's stock is held by institutional investors, 25.77% is held by insiders, and 43.79% is held by retail investors.
    What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 12.89% of Amneal Pharmaceuticals Inc (AMRX) stock is held by institutional investors.
      What percentage of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 43.79% of Amneal Pharmaceuticals Inc (AMRX) stock is held by retail investors.
        Who owns the most shares of Amneal Pharmaceuticals Inc (AMRX)?
        Mahesh Akram owns the most shares of Amneal Pharmaceuticals Inc (AMRX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis